Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol versus local anesthesia infiltration for surgical field optimization in dacryocystorhinostomy under total intravenous anesthesia
PACTR202608469521329Phase 4Unknown
- Sponsor
- Omnia Mahmoud El Dosuky Saleh Heikal
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of labetalol and ropivacaine in dacryostenosis (2 arms), sponsored by Omnia Mahmoud El Dosuky Saleh Heikal. Primary endpoint: Surgical field quality. Status: unknown.
02
Drugs
labetalolropivacaine
03
Conditions
dacryostenosis
Beyond the preview
Go deeper on PACTR202608469521329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608469521329.